Exercise manages fatigue during breast cancer treatment: A randomized controlled trial
Top Cited Papers
- 14 October 2004
- journal article
- clinical trial
- Published by Wiley in Psycho‐Oncology
- Vol. 14 (6), 464-477
- https://doi.org/10.1002/pon.863
Abstract
Fatigue is the most prevalent and debilitating symptom experienced by breast cancer patients receiving adjuvant chemotherapy or radiation therapy and few evidence‐based treatments are available to manage this distressing side‐effect. The purpose of this multi‐institutional randomized controlled trial was to determine the effects of exercise on fatigue levels during treatment for breast cancer. Sedentary women (N=119) with Stage 0–III breast cancer receiving outpatient adjuvant chemotherapy or radiation therapy were randomized to a home‐based moderate‐intensity walking exercise program or to usual care for the duration of their cancer treatment. Of participants randomized to exercise, 72% adhered to the exercise prescription; 61% of the usual care group adhered. The intention‐to‐treat analysis revealed no group differences in part because of a dilution of treatment effect as 39% of the usual care group exercised and 28% of the exercise group did not. When exercise participation was considered using the data analysis method of instrumental variables with principal stratification, a clinically important and statistically significant (p=0.03) effect of exercise on pretest‐to‐posttest change in fatigue levels was demonstrated. Adherence to a home‐based moderate‐intensity walking exercise program may effectively mitigate the high levels of fatigue prevalent during cancer treatment. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 50 references indexed in Scilit:
- Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-upThe British Journal of Psychiatry, 2003
- Clinical Excellence Through Evidence-Based Practice: Fatigue Management as a ModelOncology Nursing Forum, 2003
- Analyzing a Randomized Cancer Prevention Trial with a Missing Binary Outcome, an Auxiliary Variable, and All-or-None ComplianceJournal of the American Statistical Association, 2000
- Fatigue in Women Receiving Adjuvant Chemotherapy for Breast CancerJournal of Pain and Symptom Management, 1999
- Analysis of Survival Data from a Randomized Trial with All-or-None Compliance: Estimating the Cost-Effectiveness of a Cancer Screening ProgramJournal of the American Statistical Association, 1998
- Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized TrialJournal of the American Statistical Association, 1994
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug ProjectNew England Journal of Medicine, 1980
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979